The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know

from Mercalis in Motion · host TrialCard

The Drug Provisions within the Inflation Reduction Act (IRA) of 2022 are of critical importance to pharmaceutical manufacturers, who now have a host of new considerations when thinking through their portfolio strategies and pricing and market access considerations. In this episode of TrialCard TALK, Landy and Eric welcome to the studio two experts on the topic: Megan Thomas, Partner, Triangle Insights Group and Jason Zemcik, Principal Consultant for Policy Reporter.

Episode metadata supplied by the publisher feed · Published Jul 19, 2023

Embed this episode

Attribution link and audio player

Ready to play

The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know

0:00 31:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Mercalis in Motion?

This episode is 31 minutes long.

When was this Mercalis in Motion episode published?

This episode was published on July 19, 2023.

Can I download this Mercalis in Motion episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!